Proud of Dermatologica Sinica, a high-quality journal!

INNOVATIONS AND REFLECTIONS Time flies and my term as the Editor-in-Chief of Dermatologica Sinica (DS) is coming to an end. So, it’s now a good time to look back and check what we have achieved. The innovations over the past 3 years include the introduction of Reviewer Bank and Statistics Editors to facilitate peer review, as well as the recruitment of Social Media Editors to promote our journal. The entire editorial team has been diligent over the past 3 years and maintained the quality of articles published in the DS. Most Editors, including myself, have been rejected at least once by the DS. The acceptance rate of our journal was 24% in 2023. The impact factor (an index that not all the scholars agree but have to use) of the DS is expected to stay in the 2-point tier next year. We are now proud to say loudly “DS is a high-quality journal!” and “Happy 42nd anniversary of DS!” THIS ISSUE OFDERMATOLOGICA SINICA The treatments for keloids remain intralesional corticosteroid injection and cryotherapy, with no substantial advances over the past decades. Zhou et al. found overexpression of insulin-like growth factor-binding protein 3 in keloids, which can be inhibited by a type V transforming growth factor-β receptor (TβR-V).[1] Targeting TβR-V could thus be a potential therapeutic target for keloids but awaits further confirmatory trials. Burn scars and hyperpigmentation are difficult to treat. Huang et al. performed a pilot randomized study to examine whether combining fractional CO2 laser and topical tranexamic acid has synergistic effects. However, no significant benefit from the addition of topical tranexamic acid was detected.[2] Further improvements of the combination protocol are needed. The COVID-19 pandemic has hastened the uptake of online educational technology, but it was unclear if online classes could replace in-person classes. Wu et al. compared the effects of online versus in-person learning in scabies education for medical students.[3] Their study found the latter had better interaction and engagement which are important in keeping the motivation and self-regulation of students. Can et al. reported impressive effectiveness of adding probiotic supplementation in managing chronic spontaneous urticaria.[4] However, the interpretation of the results should be conservative due to the nonrandomized study design and lack of placebo and blinding.[5-7] Janus kinase (JAK) inhibitors are gaining popularity due to their therapeutic potential. Li et al. illustrated a case of prurigo nodularis successfully managed by abrocitinib.[8] On the other hand, Hsiao and Lin reported a case of abrocitinib-related rhabdomyolysis.[9] Therefore, dermatologists should keep alertness while enjoying the success of using magic JAK inhibitors in treating difficult cases. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.